Introduction
The aminopropyl groups in spermidine and spermine are obtained from S-adenosylmethionine (AdoMet) after its decarboxylation by the action of the enzyme S-adenosylmethionine decarboxylase (AcloMetDC) [ 1, 2] . Once decarboxylated, AdoMet no longer serves as a methyl donor. AdoMetDC is, therefore, not only critical for polyamine biosynthesis but plays a key role in determining the disposition of the cellular AdoMet pools. AdoMetDC is very highly regulated with activity responding to stimuli that induce changes in polyamine content and to changes in the polyamine pools. The importance of such regulation in the disposition of AdoMet can be demonstrated by inhibiting the synthesis of polyamines with a-difluoromethylornithine. This prevents the synthesis of putrescine, and the aminopropyltransferases that form spermidine and spermine cannot then use the decarboxylated AdoMet (dcAdoMet). The decrease in polyamine concentration, however, leads to an elevation in AdoMetDC activity at a time when utilization of dcAdoMet is prevented. The combined effects of these changes are to increase decarboxylated AdoMet from approx. 1-2% of the AdoMet to 400% of the AdoMet content [2] .
This paper provides an overview of the structure, function and regulation of mammalian AdoMetDC. Several more detailed reviews of this enzyme and the polyamine pathway are available and provide complete citation lists for this topic [3-61. 
Structure and function of AdoMetDC
All AdoMetDCs have a covalently linked pyruvoyl prosthetic group that forms a Schiff base with the substrate, AdoMet [5, 7] . This provides an electron sink that facilitates the removal of the carboxylate group. The loss of this group relinquishes a negative charge to the remaining portion of the substrate and protonation at the a-carbon is required in order to form dcAdoMet, which is then released (Figure 1 ).
All pyruvoyl enzymes are formed as a proenzyme (n) chain which then undergoes an internal cleavage to generate two subunits (a and p) and the pyruvate prosthetic group [5, 7] . Processing of the human AdoMetDC (hAdoMetDC) proenzyme, which is shown in Figure 2 , occurs with cleavage at the sequence YVLSE-SSMFMV (the serine that generates pyruvate is underlined), which is highly conserved in all AdoMetDCs except Eschenkhia coli, which has the sequence The processing reaction proceeds via an intermediate ester that is formed from a nucleophilic attack of the hydroxyl oxygen of the serine, which forms the pyruvate, at the amide carbonyl group of the preceding amino acid. This ester undergoes a /?-elimination to generate the /? chain and the a chain containing a dehydroalanine residue at its amino terminus. The dehydroalanine is then converted into the pyruvate with release of ammonia via the formation of imine and carbinolamine intermediates. The N -0 acyl rearrangement involving a serine residue in this mechanism is identical to the initial step in protein splicing reactions [8] . In this case, the ester intermediate undergoes a transesterification instead of the /?-elimination reaction.
The processed hAdoMetDC consists of a dimer (a2p2) of the two non-identical subunits.
The 7 kDa /? subunit contains 67 amino acid residues and the 31 kDa a subunit contains the N-terminal pyruvate and 266 amino acid residues ( Figure 2 ). Very recently, the crystal structure for hAdoMetDC has been solved [9] . The availability of this structure will be extremely valuable in the interpretation of results obtained with mutants described below and should also provide a basis for the design of more specific and potent inhibitors. Such drugs have considerable potential as both anti-neoplastic and anti-parasitic agents AHLDK-SHICV.
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Studies by site-directed mutagenesis have identified several residues as likely to play key roles in AdoMetDC activity. These include residues Glu-8, Glu-1 1, Cys-82, His-127, Glu-133, Thr-245 and Glu-256 ( [3, 4, 11, 12] ; H. Xiong and A. E. Pegg, unpublished work) . Mutations at these sites, which are all present in conserved regions and are themselves conserved in all AdoMetDC sequences, do not block processing (although, in some cases they slow its rate) but reduce activity by more than 90%. The presence of the essential residues Glu-8 and Glu-11 in the small / 3 subunit show that this subunit forms part of the active site. Residue Glu-133 is likely to be involved in binding the AdoMet substrate because its conversion into Gln (Glu-133Gln) causes a 50-fold increase in the K, [12] .
Residue Cys-82 may represent the essential proton donor (H. Xiong The processing of the AdoMetDC proenzyme appears to be autocatalytic. It can certainly proceed in the absence of other proteins but a role for other cellular components including proteins that may act as chaperones, either to facilitate the processing reaction or to prevent incorrect folding of the proenzyme, is possible. The evolution of the AdoMetDC sequence to allow it not only to provide a suitable site to efficiently bring about the decarboxylation reaction but also to bring about the processing reaction to form its own prosthetic group, is an Mutation of the critical serine to alanine completely prevents processing and the formation of active enzyme from AdoMetDC proenzyme [14] . The serine can be mutated to cysteine or threonine in the human or potato AdoMetDC and processing still occurs, although more slowly [15] . The serine to cysteine mutant can form pyruvate (generating a thiocarboxylate in the glutamate at the C terminal of the subunit) and this mutant was still active. The threonine mutant forms an a-ketobutyrate prosthetic group and this protein was inactive.
Several other point mutations prevent or dramatically slow the processing reaction of hAdoMetDC. These include Ala-326Stop (deleting nine residues from the C terminal), and GlullLys, Ser-229Ala and His-243Ala, which are all in highly conserved regions ( [12, 15] ; H. Xiong and A. E. Pegg, unpublished work). The effect of the C-terminal truncation occurs despite the fact that there are no conserved residues after position 280 and suggests that the length of the polypeptide chain is critical for processing [15] . [21] . Alteration in the amount of AdoMetDC protein appears to be the most common way for activity to be regulated. The only exception to this is the stimulation of the enzymic activity by putrescine [2, 22] .
( I ) Regulation of AdoMetDC catalytic activity
The activity of yeast, Trypanosoma brucei, T. cruzi, Onchocerca volvulus and mammalian AdoMetDC is stimulated by putrescine [22-251. This stimulation is caused by a conformational change in the protein that causes a reduction in the K, for AdoMet. The activation is pH dependent, and occurs to a greater extent at more acidic pH. The higher polyamines, spermidine and spermine, do not increase activity and in most cases actually inhibit the putrescinestimulated reaction.
It is very likely that interaction of the putrescine with acidic residues in the hAdoMetDC causes this conformational change. Mutation of any one of the acidic residues located at Volume 26 positions 174, 178 and 256 to the corresponding amide (i.e. Asp-l74Asn, Glu-l78Gln, and Glu256Gln) abolishes the stimulation of hAdoMetDC [12, 15] . These are three residues of the four sites described below as being needed for putrescine activation of processing; the fourth residue (Glu-11) can not be tested in this way because the Glu-1 lGln mutant is inactive. Plant AdoMetDCs are not activated, presumably owing to the absence of the acidic residue equivalent to Asp-1 74 [ 151. However, trypanosomal AdoMetDCs have a serine at the position equivalent to Glu-178 [24] . It is possible that another acidic residue can substitute for Glu-178 or a bond can be made by putrescine with the hydroxyl group of serine in these parasite AdoMetDCs.
(2) Regulation of AdoMetDC proenzyme processing
The rate of processing of the mammalian and yeast AdoMetDC proenzymes is increased by the addition of putrescine [26] . This stimulation potentially provides a mechanism by which putrescine might increase the level of active AdoMetDC. In most cell extracts, the percentage of the AdoMetDC protein in the 38 kDa (z) proenzyme form is very small, suggesting that normal cellular levels may be sufficient for optimal processing. However, studies with cells treated with inhibitors of putrescine production, such as a-difluoromethylornithine, do show an increase in the fraction of AdoMetDC that is present as the unprocessed K form. Conversely, manipulations that increase putrescine content reduce this to undetectable levels [27] .
The acceleration of AdoMetDC proenzyme processing by putrescine presumably is caused by a change in the conformation of the proenzyme in response to the binding of putrescine to a form that favours the reaction. The interaction of the positively charged diamine is likely to involve ionic interactions with at least four acidic residues in the AdoMetDC protein. Four residues with carboy1 side chains (Glu-11, Asp-174, Glu-178 and Glu-256 in hAdoMetDC) are essential for this activation. Mutation of any one of these to the corresponding amide abolishes the stimulation [ 12,151. Plant AdoMetDCs lack the acidic residue equivalent to Asp-174 and this presumably accounts for the lack of putrescine activation of their processing.
Despite the apparent similarity between the putrescine activation of activity and processing, these appear to involve different mechanisms.
Although much higher concentrations are required, 4-aminobutanol is able to mimic the acceleration of the processing rate of the hAdoMetDC by putrescine but 4-aminobutanol has no effect on activity (H. Xiong and A. E. Pegg, unpublished work). Experiments with plasmid constructs containing portions of the hAdoMetDC promoter [36] fused to a reporter gene have suggested that a spermidine-responsive element may exist within this region [37] . However, the presence of a part of the 5' untranslated region (UTR) of the AdoMetDC mRNA in these constructs may complicate the interpretations because, as described below, this element may impart translational regulation. Insulin increases AdoMetDC mRNA synthesis and an insulin-responsive element was found in the rat AdoMetDC promoter [38] . [4,17,18,28,30,32,37,39] . Secondly, pulse labelling studies are consistent with translational regulation [20, 32] . Thirdly, changes in the polysomal distribution profiles of the AdoMetDC mRNA indicate alterations in the translation of AdoMetDC. mRNA in cells treated with growth factors or inhibitors of ornithine decarboxylase [40-421. Finally, studies described below in which the translation of AdoMetDC or constructs using its 5' UTR has been studied in vitro or in vivo provide direct evidence for such regulation.
The translation of mammalian AdoMetDC mRNA is very effectively repressed by polyamines. Initial studies on this repression were carried out using reticulocyte lysates and hAdoMetDC mRNA [43]. These were followed by experiments in which mammalian cells were transfected with plasmids expressing either full length AdoMetDC mRNA or the mRNA with deletions in the 5' UTR [37, 44] . (All mammalian AdoMetDC mRNAs contain a long 5' UTR of about 330 nucleotides, the sequence of which is very highly conserved [28, 36] .) The results indicated that secondary structure in the 5' UTR was not a key factor in translational regulation and that reading of the AdoMetDC mRNA was not regulated by eIF-4E [44, 45] .
Subsequently, more detailed studies in which the 5' UTR of AdoMetDC has been fused to a reporter gene have shown that the 5' UTR of the AdoMetDC mRNA is strongly inhibitory to translation. The 5' UTR contains a polyamine responsive element that reduces translation in the presence of spermidine or spermine This upstream ORF was also more effective at suppressing translation in some cell types, such as T lymphocytes, than others, thus accounting for cell specific effects in AdoMetDC synthesis [42, 47] . However, in contrast with the regulation by polyamines, this effect is related to the position of the ORF, which must be close to the message cap site.
The amino acid sequence that is encoded by the upstream ORF is critical for regulation. The 18 nucleotide ORF potentially codes for the hexapeptide Met-Ala-Gly-Asp-Ile-Ser. Alteration of the nucleotide sequence (by incorporating all of the possible changes that can be made without affecting the amino acids encoded) did not abolish the regulation; however, changes that altered some of the amino acids eliminated the response. These studies indicate that, in order for the sequence to confer regulation, it must code for a peptide, Met-ha-ha-Asp-Ile-Ser [41, 42] . Although the Met-ha-ha-Asp-Ile-Ser sequence appears to impart regulation by either spermidine or spermine, studies in which both polyamines were reduced by using inhibitors of ornithine decarboxylase and spermine synthase and replacing the polyamines individually indicate that spermine is more potent in repressing AdoMetDC (L. M. Shantz, A. E. Pegg and D. R.
Morris, unpublished work).
The most plausible mechanism for the translational regulation is that the upstream ORF in the 5' UTR of AdoMetDC mRNA causes ribosome stalling, which reduces the frequency of translation of the downstream ORF encoding AdoMetDC. Two factors contribute to this stalling, one is the sequence of the upstream ORF and the other is the content of cellular polyamines. At high polyamine levels, stalling occurs more effectively. The biochemical mechanism by which the Met-Xaa-ha-Asp-Ile-Ser nascent peptide interacts with polyamines is not yet known but is of great potential interest.
(5) Regulation of AdoMetDC degradation
AdoMetDC hs a short half-life with a tIl2 of about 1-2 h depending on the cell type [4, 18, 19, 22, 32] . Many stimuli known to alter AdoMetDC activity also cause a change in the turnover rate of the protein [4] . This may be related primarily to the fact that the tlI2 of AdoMetDC is inversely related to the cellular content of spermidine and spermine but growth stimuli that increase AdoMetDC may act in part by directly prolonging the life of the protein. The increased degradation when levels of these polyamines are high may be an important control mechanism in maintaining AdoMetDC levels that reinforces their effects on transcription and translation.
The rapid turnover of AdoMetDC is inhibited by the binding of inhibitors such as methylglyoxal bis (guanyl) hydrazone [48], aminoguanidine [30], S-methyl-5'-methylthioadenosine [49] or 4-amidinoindan-1-one 2'-amidinohydrazone [30] and these inhibitors therefore lead directly to a major increase in the amount of enzyme protein [2] . This can result in a paradoxical increase in enzyme activity in response to the administration of such inhibitors particularly at the time period shortly after the inhibitor concentration starts to decline.
At present, the mechanisms for the degradation of AdoMetDC and for alteration in degradaVolume 26 tion rate in response to polyamines, inhibitors and other stimuli are unknown. It is possible that the binding of inhibitors at the active site changes the configuration of the protein to a form resistant to recognition by the degradation machinery.
Another possibility is that the rapid turnover of AdoMetDC is related to the substrate-induced transamination reaction (see Figure 1) . In all enzymatic decarboxylation reactions, protonation (which should occur on the a carbon of the substrate) occurs occasionally on the closely located carbon in the prosthetic group leading to transamination of the cofactor. With vitamin B,-dependent enzymes, this converts the pyridoxal 5'-phosphate to pyridoxamine 5'-phosphate but the latter can be replaced with another molecule of pyridoxal 5'-phosphate. With pyruvoyl enzymes, the prosthetic group is covalently bound. Therefore, transamination, which converts the pyruvate to an alanine, permanently inactivates the enzymes (Figure 1 , transamination pathway). The rapid degradation of this useless protein would make physiological sense. The possibility that the transaminated form of AdoMetDC with alanine in place of pyruvate is the target for degradation is therefore worth considering. This would explain why inhibitors of the reaction stabilize AdoMetDC as these, in general, decrease the number of catalytic turnovers. One exception to this is the inhibitor, 
